LAG-3 and TIGIT expression may predict skin melanoma progression and survival. Discover how these immune markers could shape future therapies. Read more.

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

In multivariable analysis, six clinicopathologic variables were significantly associated with time to recurrence: ulceration, tumor thickness, tumor location, neurotropism (tumor growth along nerves), ...

DEAR DR. ROACH: Can you define the characteristics of the four stages of cancer? I understand that stage I is generally when cancer is caught early and can be treated with a good success rate, while ...

Investigators sought to determine whether adjuvant pembrolizumab is associated with the risk of developing subsequent cutaneous malignant neoplasms in patients with high-risk stage II melanoma.

Melanoma in situ (MIS), also called stage 0 melanoma, is the earliest stage of melanoma, when the cancer is confined to the outermost layer of skin. Most melanomas affect the skin, but they can also ...

Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at ...